4 When laboratory diagnosis is indicated, current recommendations include using a 2-tier testing approach that begins with a sensitive enzyme immunoassay (EIA), followed by a confirmatory immunoassay for specimens yielding positive or equivocal results.
Quest offers testing in accordance with the Centers for Disease Control and Prevention (CDC) guidelines for early/acute Lyme disease testing.
